Discover
PHAT
Phathom Pharmaceuticals, Inc.
10.54
2 x 7.85
2 x 13.44
bid
ask
-
0.31
2.90%
2 @ 07:03 AM
10.69 +0.15 (1.47%)
| Ytd | -36.50% | |
| 1y | 18.24% |
10.42
day range
11.01
7.61
52 week range
18.31
| Open | 10.85 | Prev Close | 10.85 | Low | 10.42 | High | 11.01 | Mkt Cap | 840.23M |
| Vol | 901.34K | Avg Vol | 1.19M | EPS | -2.09 | P/E | N/A | Forward P/E | 7.60 |
| Beta | 0.61 | Short Ratio | 9.36 | Inst. Own | 83.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 04-30 | 50-d Avg | 11.16 | 200-d Avg | 12.70 | 1yr Est | 23.70 |
| Income Statement | |||
| Total Revenue | 58.30M | ||
| Revenues (USD) | 58.30M | ||
| Cost of Revenue | 12.00M | ||
| Gross Profit | 46.31M | ||
| Operating Expenses | 61.78M | ||
| Research and Development Expense | 7.77M | ||
| Selling, General and Administrative Expense | 54.01M | ||
| Operating Income | -15.48M | ||
| Interest Expense | 15.80M | ||
| Net Income | -30.37M | ||
| Net Income Common Stock | -30.37M | ||
| Net Income Common Stock (USD) | -30.37M | ||
| Consolidated Income | -30.37M | ||
| Earnings per Basic Share | -0.37 | ||
| Earnings per Basic Share (USD) | -0.37 | ||
| Earnings per Diluted Share | -0.37 | ||
| Earning Before Interest & Taxes (EBIT) | -14.57M | ||
| Earning Before Interest & Taxes (USD) | -14.57M | ||
| Weighted Average Shares | 82.05M | ||
| Weighted Average Shares Diluted | 82.05M | ||
| Balance Sheet | |||
| Cash and Equivalents | 183.77M | ||
| Cash and Equivalents (USD) | 183.77M | ||
| Trade and Non-Trade Receivables | 80.72M | ||
| Current Assets | 276.57M | ||
| Property, Plant & Equipment Net | 3.52M | ||
| Total Assets | 305.12M | ||
| Debt Current | 667.00K | ||
| Total Debt | 514.20M | ||
| Current Liabilities | 125.04M | ||
| Debt Non-Current | 513.53M | ||
| Total Liabilities | 642.08M | ||
| Accumulated Retained Earnings (Deficit) | -1.51B | ||
| Shareholders Equity | -336.95M | ||
| Shareholders Equity (USD) | -336.95M | ||
| Assets Non-Current | 28.55M | ||
| Total Debt (USD) | 514.20M | ||
| Inventory | 25.58M | ||
| Liabilities Non-Current | 517.03M | ||
| Trade and Non-Trade Payables | 6.37M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 110.00K | ||
| Net Cash Flow from Financing | 66.64M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 50.93M | ||
| Capital Expenditure | -61.00K | ||
| Issuance (Purchase) of Equity Shares | 122.57M | ||
| Issuance (Repayment) of Debt Securities | -55.80M | ||
| Net Cash Flow from Investing | -61.00K | ||
| Net Cash Flow from Operations | -15.65M | ||
| Share Based Compensation | 5.53M | ||